SAGE - Sage Therapeutics GAAP EPS of -$2.68 misses by $0.11 revenue of $2.47M misses by $0.44M August, 07 2023 06:30 AM Sage Therapeutics Inc. 2023-08-07 06:30:59 ET Sage Therapeutics press release ( NASDAQ: SAGE ): Q2 GAAP EPS of -$2.68 misses by $0.11 . Revenue of $2.47M (+64.7% Y/Y) misses by $0.44M . For further details see: Sage Therapeutics GAAP EPS of -$2.68 misses by $0.11, revenue of $2.47M misses by $0.44M